Benitec Biopharma Inc. - 8-K Filing
Benitec Biopharma reported a $45.5M net loss in FY2026 but maintained $180M cash balance as BB-301 clinical trials advance. (Items: 2.02 Results of Operations and Financial Condition, 9.01 Financial Statements and Exhibits)
Tickers: $BNTC